Vysokodávkovaná chemoterapie s podporou autologních hemopoetických bunĕk v terapii mnohocetného myelomu--prehled soucasných mozností
[High-dosage chemotherapy with support of autologous haematopoietic cells in the treatment of multiple myeloma--review of contemporary possibilities]
Vnitrni lekarstvi.
2001 Feb ;
47 (2) :
92-8.
Language Czech Country Czech Republic Media print
Document type English Abstract, Journal Article, Review
Persistent link
https://www.medvik.cz/link/pmid15635853
PubMed
15635853
- MeSH
- Transplantation, Autologous MeSH
- Combined Modality Therapy MeSH
- Humans MeSH
- Multiple Myeloma therapy MeSH
- Antineoplastic Agents administration & dosage MeSH
- Hematopoietic Stem Cell Transplantation * MeSH
- Check Tag
- Humans MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Antineoplastic Agents MeSH
High-dosage chemotherapy with autologous transplantation of haematopietic stem cells prolonged the survival of patients with multiple myeloma as compared with results of standard chemotherapy, on average by 1.5 years. Nowadays this method is the standard treatment for suitable patients. Findings assembled recently are discussed by the authors.
